Medicare's contractor advisory committees have evolved greatly from 2005, to 2015, to the present (2019 forward). I've put the Medicare LCD Manual from each period into one cloud zip file (here).
I asked Claude Opus to evaluate those three files, and compare CAC meetings under each era.
###
From Carrier to Contractor: How Medicare Rebuilt the CAC Between 2004 and 2019
A reading of three Program Integrity Manual layers — and why today's Contractor Advisory Committee looks nothing like the standing state roster of 2005.
If you have ever sat on a Carrier Advisory Committee, the modern CAC can be disorienting. The thing many of us remember from 2005 was a standing roster of specialists — one seat per specialty society, often fifteen or twenty members, meeting quarterly in a hotel conference room, receiving each draft Local Coverage Determination as it went out the door to public comment. The thing we attend in 2026 is something else entirely: a half-dozen experts, frequently national rather than in-state, convened for a single afternoon to work through ten or twelve structured questions about the evidence on a topic that does not yet have a draft LCD attached to it — the whole session recorded and posted as a transcript.
That transformation is fully documented in three sedimentary layers of one manual chapter. Reading them in sequence shows that the change was not a gradual drift. It was a single, discontinuous response to a statute, bolted onto more than a decade of deferred housekeeping.
Read the revision stamps first
The three documents are not freestanding policies. They are the same Program Integrity Manual section at three points in time, and the revision stamps tell most of the story before you read a word of substance.
The 2004 text carries Rev. 63 (01-23-04) and sits in the old PIM numbering as §8.1. The 2015 text is the same manual, renumbered to §13.8.1, but its bones are still Rev. 71 (04-09-04), with the structure-and-process subsection bumped only to Rev. 473 (06-21-13). The 2019 text is a different creature altogether: Rev. 863, issued 02-12-19, effective 10-03-18, implementation January 8, 2019, relocated to §13.2.4.3.
That January 8, 2019 date is the tell. It is the go-live date of CMS's wholesale rewrite of the LCD process, issued under Change Request 10901 to carry out Section 4009 of the 21st Century Cures Act (P.L. 114-255, signed December 13, 2016), codified at Social Security Act §1862(l)(5)(D). So you are really comparing two eras, not three: a carrier-era artifact that barely moved between 2004 and 2015, and a Cures-driven reconstruction in 2019.
Sidebar — The CAC across three manual layers
| Feature | 2004 (Rev. 63) | 2015 (Rev. 71 / 473) | 2019 (Rev. 863) |
|---|---|---|---|
| Name | Carrier Advisory Committee | Carrier Advisory Committee (text still says "Carriers") | Contractor Advisory Committee; actor is the MAC |
| Geography | One CAC per state, rigidly | One CAC per state, rigidly | Per state, per jurisdiction, or multi-jurisdictional / multi-MAC |
| Membership theory | Specialty representation; one seat + alternate per specialty | Same | Evidence expertise; "more voices" (nurses, epidemiologists, etc.) |
| Core function | Dissemination & liaison; carry drafts to societies | Same | Review the quality of the evidence |
| Link to comment clock | 45-day clock starts on distribution to the committee | Same | Severed; comment period is a separate statutory step |
| Timing vs. draft | CAC reviews the draft LCD as released | Same | May meet before a proposed LCD exists, on the topic's evidence |
| Cadence | ≥ 3 meetings/year, ≤ 4 months apart | Same | No minimum; MAC sets frequency by LCD volume |
| Leadership | CMD + elected physician co-chair; 2–3 yr tenure | Same | Co-chair / tenure language dropped; MAC approves members |
| Transparency | Minutes to members & RO; web posting optional | Same (+ PSC/GTL overlay) | Recorded (audio/video), public, posted as LCD record |
| Compensation | None; voluntary service | None | None (the one provision carried forward verbatim) |
2004–2015: the standing state roster as a representation machine
In the first era the committee is the Carrier Advisory Committee, and almost every structural choice flows from that one word. One CAC per state; where a carrier spanned several states, each state got "a full committee and the opportunity to discuss draft LCDs." The committee was built around specialty representation: one member plus a designated alternate per specialty, with additional specialists pulled in when their expertise was implicated. In practice that produces exactly the body many of us remember — a standing roster running to fifteen or twenty seats, because the design goal was to have the relevant society's voice already in the room for whatever LCD surfaced.
The functional theory was dissemination and liaison, not adjudication of evidence. The "Role of CAC Members" section is explicit: members existed to carry proposed LCDs back out to their state and specialty societies to solicit comment, to carry Medicare program information back in, and to flag inconsistent or conflicting medical-review policy. They were conduits. The contractor medical director co-chaired with one physician elected by the committee, and the co-chairs set the agenda and pushed background material out at least fourteen days ahead.
Two features matter most for understanding what later broke. First, the CAC was wired directly into the comment clock: the 45-day comment period "starts when the proposed LCD is distributed to the committee members," and the co-chairs "present all proposed LCDs to the CAC for discussion." The CAC meeting was the public-facing event for a draft LCD — which is precisely the co-distribution-to-CAC-and-public simultaneity of the 2005 model. Second, the cadence was fixed and frequent: a minimum of three meetings a year, no more than four months apart. That is a standing quarterly body by design, because a standing body is what you need when the committee is the routing point for every draft in the jurisdiction.
What is striking is how little changed by 2015. The Medicare Modernization Act had already replaced carriers with A/B MACs years earlier, yet the 2015 text still says "Carriers shall establish," still says one CAC per state, still prescribes three meetings a year, still triggers the comment clock on distribution to the committee, still names an elected physician co-chair, still suggests two- to three-year tenures. The only real accretion is a maintenance overlay reflecting the program-integrity contractor apparatus — the parenthetical "(for PSCs, the GTL, Co-GTL, and SME)" threaded through the directory, waiver, and recordkeeping provisions — plus the 2013 (Rev. 473) refresh of the structure section. Between 2004 and 2015, CMS updated the plumbing references and left the committee's constitutional theory entirely intact. The 2015 document is a carrier-era document wearing a MAC-era nametag.
2019: the Cures rupture
The 2019 rewrite changes the committee's purpose, not merely its logistics, and nearly everything else follows from that.
Carrier becomes Contractor. The committee is renamed, the actor throughout is "MACs," and the carrier vocabulary is finally retired a decade and a half late.
The geographic unit is loosened. Where the old rule was rigidly one-CAC-per-state, 2019 permits one CAC per state, one per jurisdiction, or a multi-jurisdictional CAC with representation from each state — and CMS's companion LCD Process Q&A confirms that multi-MAC CACs are also on the table. This is the textual hinge that permits the modern reality. Once you may convene a single panel for an eleven-state jurisdiction, the chair of pathology at one academic center and the chair at another become natural picks, because you are no longer staffing for in-state representation. You are staffing for the best available evidence reviewers.
Representation becomes evidence review. This is the conceptual core. The old purpose — a formal mechanism for physicians in the state to be informed of and participate in LCD development, plus a liaison forum — is replaced by a purpose centered on the evidence: members "review the quality of the evidence used in the development of an LCD." CMS said the quiet part plainly in the Q&A: because Cures now requires LCDs to include a summary of the evidence considered and a rationale, the role of CAC members should evolve to reviewing the quality of that evidence instead of only representing a constituency. The 2019 language even imports the deliberative register of the national MEDCAC — advice is "most useful when it results from a process of full scientific inquiry and thoughtful discussion with careful framing of recommendations," and the panel exists to ensure an "unbiased and contemporary consideration of 'state of the art' technology and science." That is consciously MEDCAC-style framing dropped onto a local body.
The comment-clock coupling is severed. Note what disappears: the entire mechanism by which distributing a draft LCD to the committee started the 45-day clock, and the instruction that co-chairs present "all proposed LCDs" to the CAC. This is the most consequential deletion. Cures created, by statute, a separate and mandatory public process — the MAC must post the determination in its entirety, identify where and when it was first made public, and supply a rationale, at least forty-five days before the effective date. Once the open public-comment period and the proposed-LCD posting are independent statutory steps, the CAC no longer needs to be the comment vehicle. It is freed to move upstream: it now convenes around a contemplated topic and its evidence base. The Q&A makes the new optionality explicit — a MAC may host the CAC before posting a proposed LCD, to inform the upfront analysis, or after. That is exactly the shift from the 2005 picture (draft presented to the roster, co-distributed to the public, clock running) to the 2026 picture (a future topic, structured evidence questions, no draft on the table yet).
Transparency is mandated, and it reshapes the format. The 2019 rule requires the MAC to record every CAC meeting — video, audio, or both — and to maintain that recording on the contractor website as part of the LCD record. All CAC meetings are open to the public to attend and observe; only the non-evidence portions (provider practice-trend reporting, fraud-and-abuse discussion) may be closed. The old regime asked only for minutes distributed to members and forwarded to the regional office within ten days, with web posting optional and FOIA-redacted. The published transcript of a modern CAC is the direct artifact of this recording-and-posting mandate, and the structured, ten-to-twelve-question, roughly two-hour format is the natural operational form of "review the quality of the evidence" plus "careful framing of recommendations." It is a local echo of the MEDCAC voting-question script, engineered to produce a clean, citable evidentiary record rather than a roundtable of society liaisons.
The standing body dissolves into an ad hoc panel. Several deletions point the same way. The fixed cadence is gone; the Q&A confirms MACs now set frequency "based on the appropriateness and volume of LCDs requiring CAC input," and a CAC is not required for every LCD. The two- to three-year tenure guidance is gone. The elected physician co-chair structure is gone; member approval now rests simply with the MAC. The dissemination-to-societies role is gone, because the statutory public-comment process now performs that solicitation directly and at scale. The reference to the Practicing Physicians Advisory Council is gone (PPAC itself had been sunset earlier in the decade). The substitution rule tightens and formalizes — a substitute may attend only if the MAC is notified and approves at least one week ahead — which is the housekeeping you would expect once a meeting is a recorded, public event of record. About the only provision carried forward verbatim is the honorarium prohibition: participation remains voluntary, expenses on the member or the society.
The net trajectory — and why 2015 is the instructive case
Put the two eras side by side and the arc is coherent. The carrier-era CAC was a representative standing committee — a per-state roster of society delegates, meeting quarterly, functioning as the routing point and comment trigger for draft LCDs, steered by the contractor medical director and an elected physician. The Cures-era CAC is an evidence-review panel — convened at jurisdictional or multi-jurisdictional scale, often stocked with national figures chosen for expertise rather than in-state constituency, addressing a future topic through structured questions in a recorded, public, transcribed session that becomes part of the LCD record, with the comment period and the proposed-LCD posting hived off into their own statutory channels.
The 2015 document is instructive precisely because it isn't a transition. It shows that as late as 2015 CMS was content to leave the 2004 design frozen, which means the 2019 change was not a slow evolution but a single discontinuous response to a statutory mandate. The "many other ad hoc changes" — the multi-jurisdictional option, the substitution mechanics, the recording medium, the closable fraud-and-abuse portions — are best read as CMS using the Cures rewrite as the occasion to clear a decade of deferred modernization in one transmittal.
One caveat for readers who want to follow the functions rather than the committee: these provisions capture the CAC specifically. The full 2019 Chapter 13 rewrite also created or relocated the informal pre-LCD meeting, the formal open meeting, the new-LCD request process, and the comment-and-response (RTC) machinery. Those companion provisions are what make the upstream repositioning of the CAC coherent. The dissemination and comment functions the CAC used to carry did not vanish in 2019; they were redistributed into a statutory public process that the committee no longer needs to host.
Key documents
- Medicare Program Integrity Manual, Pub. 100-08, Chapter 13 — Local Coverage Determinations (current consolidated chapter; CAC at §13.2.4.3).
- CMS Transmittal R863PI (Rev. 863; CR 10901; issued 02-12-19; implementation 01-08-19) — the Cures rewrite of Chapter 13.
- CMS Fact Sheet: Summary of Significant Changes to PIM Chapter 13 — CMS's own description of the restructured CAC, "more voices," and open meetings.
- CMS LCD Process Modernization Questions & Answers — the agency's rationale for evolving the CAC role and the before/after-posting and multi-MAC options.
- 21st Century Cures Act (H.R. 34, P.L. 114-255) — Section 4009, "Improving Medicare Local Coverage Determinations," codified at SSA §1862(l)(5)(D).
#
#Alternate
Chat GPT 5.5
Core thesis
The CMS CAC evolved from a standing, state-based professional advisory committee embedded in the draft-LCD comment cycle into a more flexible, evidence-review body that MACs may convene around a topic, often before a proposed LCD is released. In 2004 and still largely in 2015, the CAC was part of the old carrier-era culture: one committee per state, regular meetings, local specialty society representation, minutes, agendas, and draft LCDs distributed to CAC members at the same time the 45-day comment period began.
By 2019, after 21st Century Cures and CMS’s broader LCD-process revisions, the CAC had become more formalized as a transparency and evidence-review mechanism: open to public observation, recorded, potentially jurisdictional or multi-jurisdictional, and explicitly focused on the quality of evidence rather than simply “local physician input.”
CMS itself described the 2018–2019 Chapter 13 revision as a response to the 21st Century Cures Act, intended to improve transparency in the LCD process. (Centers for Medicare & Medicaid Services)
